0001209191-18-017352.txt : 20180306
0001209191-18-017352.hdr.sgml : 20180306
20180306170310
ACCESSION NUMBER: 0001209191-18-017352
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Larry G.
CENTRAL INDEX KEY: 0001733062
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35837
FILM NUMBER: 18670764
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL STREET, SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001373707
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617.715.3600
MAIL ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-03-01
0
0001373707
TETRAPHASE PHARMACEUTICALS INC
TTPH
0001733062
Edwards Larry G.
C/O TETRAPHASE PHARMACEUTICALS, INC.
480 ARSENAL WAY
WATERTOWN
MA
02472
0
1
0
0
Chief Operating Officer
Common Stock
28032
D
Employee Stock Option (Right to Buy)
47.88
2025-06-30
Common Stock
60000
D
Employee Stock Option (Right to Buy)
8.47
2026-01-05
Common Stock
40000
D
Employee Stock Option (Right to Buy)
3.69
2027-01-29
Common Stock
85000
D
Employee Stock Option (Right to Buy)
8.17
2027-04-12
Common Stock
100000
D
Employee Stock Option (Right to Buy)
6.24
2028-01-16
Common Stock
115000
D
Restricted Stock Units
Common Stock
20000
D
Restricted Stock Units
Common Stock
32000
D
This option vests over four years. Twenty-five percent (25%) of the shares vested on July 1, 2016 and 6.25% of the shares vest at the end of each successive quarter thereafter.
Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
Vests as to 6.25% of the shares on 4/30/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/31/2021.
Vests as to 6.25% of the shares on 7/13/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 4/13/2021.
Vests as to 6.25% of the shares on 4/17/2018 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/17/2022.
The restricted stock units vest in three equal installments on each of January 6, 2017, January 6, 2018 and January 6, 2019.
Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021.
/s/Maria Stahl as Attorney-in-Fact for Larry G. Edwards
2018-03-06
EX-24.3_776279
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of Maria Stahl and Amy Quinlan, signing singly and each acting
individually, as the undersigned's true and lawful attorney in fact with full
power and authority as hereinafter described to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Tetraphase Pharmaceuticals, Inc. (the
"Company"), Forms 3, 4, and 5 (including any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to prepare, complete and execute any such Form 3,
4, or 5, prepare, complete and execute any amendment or amendments thereto, and
timely deliver and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's securities from any
third party, including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person to release any
such information to such attorney in fact and approves and ratifies any such
release of information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney in fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming nor relieving,
nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act. The undersigned
acknowledges that neither the Company nor the foregoing attorneys in fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 28th day of February, 2018.
/S/ Larry Edwards
Signature
Larry Edwards
Print Name